190 related articles for article (PubMed ID: 35453395)
1. Piperlongumine Inhibits Thioredoxin Reductase 1 by Targeting Selenocysteine Residues and Sensitizes Cancer Cells to Erastin.
Yang Y; Sun S; Xu W; Zhang Y; Yang R; Ma K; Zhang J; Xu J
Antioxidants (Basel); 2022 Apr; 11(4):. PubMed ID: 35453395
[TBL] [Abstract][Full Text] [Related]
2. Piperlongumine as a direct TrxR1 inhibitor with suppressive activity against gastric cancer.
Zou P; Xia Y; Ji J; Chen W; Zhang J; Chen X; Rajamanickam V; Chen G; Wang Z; Chen L; Wang Y; Yang S; Liang G
Cancer Lett; 2016 May; 375(1):114-126. PubMed ID: 26963494
[TBL] [Abstract][Full Text] [Related]
3. Benzophenanthridine Alkaloid Chelerythrine Elicits Necroptosis of Gastric Cancer Cells via Selective Conjugation at the Redox Hyperreactive C-Terminal Sec
Liu M; Sun S; Meng Y; Wang L; Liu H; Shi W; Zhang Q; Xu W; Sun B; Xu J
Molecules; 2023 Sep; 28(19):. PubMed ID: 37836684
[TBL] [Abstract][Full Text] [Related]
4. A Txnrd1-dependent metabolic switch alters hepatic lipogenesis, glycogen storage, and detoxification.
Iverson SV; Eriksson S; Xu J; Prigge JR; Talago EA; Meade TA; Meade ES; Capecchi MR; Arnér ES; Schmidt EE
Free Radic Biol Med; 2013 Oct; 63():369-80. PubMed ID: 23743293
[TBL] [Abstract][Full Text] [Related]
5. Menadione inhibits thioredoxin reductase 1 via arylation at the Sec
Sun S; Xu W; Zhang Y; Yang Y; Ma Q; Xu J
Free Radic Biol Med; 2021 Aug; 172():482-489. PubMed ID: 34186208
[TBL] [Abstract][Full Text] [Related]
6. Piperlongumine, a Novel TrxR1 Inhibitor, Induces Apoptosis in Hepatocellular Carcinoma Cells by ROS-Mediated ER Stress.
Zhang Q; Chen W; Lv X; Weng Q; Chen M; Cui R; Liang G; Ji J
Front Pharmacol; 2019; 10():1180. PubMed ID: 31680962
[TBL] [Abstract][Full Text] [Related]
7. Irreversible inhibition of cytosolic thioredoxin reductase 1 as a mechanistic basis for anticancer therapy.
Stafford WC; Peng X; Olofsson MH; Zhang X; Luci DK; Lu L; Cheng Q; Trésaugues L; Dexheimer TS; Coussens NP; Augsten M; Ahlzén HM; Orwar O; Östman A; Stone-Elander S; Maloney DJ; Jadhav A; Simeonov A; Linder S; Arnér ESJ
Sci Transl Med; 2018 Feb; 10(428):. PubMed ID: 29444979
[TBL] [Abstract][Full Text] [Related]
8. Chlorophyllin Inhibits Mammalian Thioredoxin Reductase 1 and Triggers Cancer Cell Death.
Sun S; Zhang Y; Xu W; Zhang Y; Yang R; Guo J; Guan S; Ma Q; Ma K; Xu J
Antioxidants (Basel); 2021 Oct; 10(11):. PubMed ID: 34829604
[TBL] [Abstract][Full Text] [Related]
9. Plumbagin reduction by thioredoxin reductase 1 possesses synergy effects with GLUT1 inhibitor on KEAP1-mutant NSCLC cells.
Sun S; Zhang Y; Xu W; Yang R; Yang Y; Guo J; Ma Q; Ma K; Zhang J; Xu J
Biomed Pharmacother; 2022 Feb; 146():112546. PubMed ID: 34954641
[TBL] [Abstract][Full Text] [Related]
10. Rapid induction of cell death by selenium-compromised thioredoxin reductase 1 but not by the fully active enzyme containing selenocysteine.
Anestål K; Arnér ES
J Biol Chem; 2003 May; 278(18):15966-72. PubMed ID: 12574159
[TBL] [Abstract][Full Text] [Related]
11. Thioredoxin reductase 1 inhibitor shikonin promotes cell necroptosis via SecTRAPs generation and oxygen-coupled redox cycling.
Zhang Y; Sun S; Xu W; Yang R; Yang Y; Guo J; Ma K; Xu J
Free Radic Biol Med; 2022 Feb; 180():52-62. PubMed ID: 34973363
[TBL] [Abstract][Full Text] [Related]
12. The production of reactive oxygen species enhanced with the reduction of menadione by active thioredoxin reductase.
Li J; Zuo X; Cheng P; Ren X; Sun S; Xu J; Holmgren A; Lu J
Metallomics; 2019 Sep; 11(9):1490-1497. PubMed ID: 31359011
[TBL] [Abstract][Full Text] [Related]
13. TXNRD1: A Key Regulator Involved in the Ferroptosis of CML Cells Induced by Cysteine Depletion In Vitro.
Liu S; Wu W; Chen Q; Zheng Z; Jiang X; Xue Y; Lin D
Oxid Med Cell Longev; 2021; 2021():7674565. PubMed ID: 34917232
[TBL] [Abstract][Full Text] [Related]
14. Hepatocyte DNA replication in growing liver requires either glutathione or a single allele of txnrd1.
Prigge JR; Eriksson S; Iverson SV; Meade TA; Capecchi MR; Arnér ES; Schmidt EE
Free Radic Biol Med; 2012 Feb; 52(4):803-10. PubMed ID: 22198266
[TBL] [Abstract][Full Text] [Related]
15. Guiding bar motif of thioredoxin reductase 1 modulates enzymatic activity and inhibitor binding by communicating with the co-factor FAD and regulating the flexible C-terminal redox motif.
Shi W; Sun S; Liu H; Meng Y; Ren K; Wang G; Liu M; Wu J; Zhang Y; Huang H; Shi M; Xu W; Ma Q; Sun B; Xu J
Redox Biol; 2024 Apr; 70():103050. PubMed ID: 38277963
[TBL] [Abstract][Full Text] [Related]
16. Acetaminophen reactive intermediates target hepatic thioredoxin reductase.
Jan YH; Heck DE; Dragomir AC; Gardner CR; Laskin DL; Laskin JD
Chem Res Toxicol; 2014 May; 27(5):882-94. PubMed ID: 24661219
[TBL] [Abstract][Full Text] [Related]
17. Piperlongumine potentiates the antitumor efficacy of oxaliplatin through ROS induction in gastric cancer cells.
Zhang P; Shi L; Zhang T; Hong L; He W; Cao P; Shen X; Zheng P; Xia Y; Zou P
Cell Oncol (Dordr); 2019 Dec; 42(6):847-860. PubMed ID: 31493144
[TBL] [Abstract][Full Text] [Related]
18. Efficient selenocysteine-dependent reduction of toxoflavin by mammalian thioredoxin reductase.
Gencheva R; Cheng Q; Arnér ESJ
Biochim Biophys Acta Gen Subj; 2018 Nov; 1862(11):2511-2517. PubMed ID: 29807072
[TBL] [Abstract][Full Text] [Related]
19. Thioredoxin Reductase Inhibition for Cancer Therapy.
Gencheva R; Arnér ESJ
Annu Rev Pharmacol Toxicol; 2022 Jan; 62():177-196. PubMed ID: 34449246
[TBL] [Abstract][Full Text] [Related]
20. Dual pharmacological inhibition of glutathione and thioredoxin systems synergizes to kill colorectal carcinoma stem cells.
Tanaka G; Inoue K; Shimizu T; Akimoto K; Kubota K
Cancer Med; 2016 Sep; 5(9):2544-57. PubMed ID: 27485632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
